Free Trial

Enlivex Therapeutics (ENLV) News Today

Enlivex Therapeutics logo
$1.02 +0.01 (+0.99%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$1.02 0.00 (0.00%)
As of 03/28/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Enlivex Therapeutics (ENLV) Projected to Post Earnings on Friday
HC Wainwright Has Bearish Estimate for ENLV FY2025 Earnings
Enlivex Therapeutics receives notice of allowance for Chinese patent
Enlivex announces interim efficacy data from Phase I Allocetra trial
Enlivex Therapeutics adopts Bitcoin treasury reserve strategy
Enlivex Initiates Promising Trial for Psoriatic Arthritis
Enlivex Advances Allocetra Trial for Knee Osteoarthritis
Enlivex Therapeutics Reschedules Annual Shareholders Meeting
Enlivex Buy Rating Affirmed on Strong Clinical and Financial Outlook
Enlivex Therapeutics Ltd. (ENLV.TA)
Valneva SE (AYJ0.BE)
Enlivex Therapeutics Ltd. stock logo
Enlivex Therapeutics (NASDAQ:ENLV) Price Target Cut to $7.00 by Analysts at HC Wainwright
HC Wainwright dropped their price objective on shares of Enlivex Therapeutics from $12.00 to $7.00 and set a "buy" rating on the stock in a research note on Friday.
Remove Ads
Get Enlivex Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENLV and its competitors with MarketBeat's FREE daily newsletter.

ENLV Media Mentions By Week

ENLV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ENLV
News Sentiment

0.12

0.81

Average
Medical
News Sentiment

ENLV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ENLV Articles
This Week

9

1

ENLV Articles
Average Week

Remove Ads
Get Enlivex Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENLV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ENLV) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners